
ABSTRACTIntroductionChronic nausea and vomiting are symptoms of a wide range of gastrointestinal and non‐gastrointestinal conditions. Diagnosis can be challenging and requires a systematic and well‐structured approach. If the initial investigation for structural, toxic and metabolic disorders is negative, digestive motility and gut‐brain interaction disorders should be assessed. United European Gastroenterology (UEG) and the European Society for Neurogastroenterology and Motility (ESNM) identified the need for an updated, evidence‐based clinical guideline for the management of chronic nausea and vomiting.MethodsA multidisciplinary team of experts in the field, including European specialists and national societies, participated in the development of the guideline. Relevant questions were addressed through a literature review and statements were developed and voted on according to a Delphi process.ResultsNinety‐eight statements were identified and voted following the Delphi process. Overall agreement was high, although the grade of scientific evidence was low in many areas. Disagreement was more evident for some pharmacological treatment options. A diagnostic algorithm was developed, focussing on the differentiating features between gastrointestinal motility and gut‐brain interaction disorders with predominant nausea and vomiting.ConclusionThese guidelines provide an evidence‐based framework for the evaluation and treatment of patients with chronic nausea and vomiting.
vomiting, Consensus, Delphi Technique, Vomiting, [SDV]Life Sciences [q-bio], 610, Guidelines, Delphi, CHRONIC INTESTINAL PSEUDOOBSTRUCTION, Neurogastroenterology, Delphi; guidelines; nausea; vomiting, CHRONIC UNEXPLAINED NAUSEA, AUTONOMIC NERVE FUNCTION, QUALITY-OF-LIFE, PROXIMAL GASTRIC-VAGOTOMY, Humans, FUNCTIONAL GASTROINTESTINAL DISORDERS, SMALL-BOWEL MOTILITY, guidelines, BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Internal Medicine., Societies, Medical, BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Interna medicina., Science & Technology, Evidence-Based Medicine, Gastroenterology & Hepatology, 3202 Clinical sciences, Gastroenterology, Nausea, nausea, GRANISETRON TRANSDERMAL SYSTEM, HIGH-RESOLUTION MANOMETRY, [SDV] Life Sciences [q-bio], Europe, Chronic Disease, Antiemetics, CANNABINOID HYPEREMESIS SYNDROME, Gastrointestinal Motility, Life Sciences & Biomedicine, Algorithms
vomiting, Consensus, Delphi Technique, Vomiting, [SDV]Life Sciences [q-bio], 610, Guidelines, Delphi, CHRONIC INTESTINAL PSEUDOOBSTRUCTION, Neurogastroenterology, Delphi; guidelines; nausea; vomiting, CHRONIC UNEXPLAINED NAUSEA, AUTONOMIC NERVE FUNCTION, QUALITY-OF-LIFE, PROXIMAL GASTRIC-VAGOTOMY, Humans, FUNCTIONAL GASTROINTESTINAL DISORDERS, SMALL-BOWEL MOTILITY, guidelines, BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Internal Medicine., Societies, Medical, BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Interna medicina., Science & Technology, Evidence-Based Medicine, Gastroenterology & Hepatology, 3202 Clinical sciences, Gastroenterology, Nausea, nausea, GRANISETRON TRANSDERMAL SYSTEM, HIGH-RESOLUTION MANOMETRY, [SDV] Life Sciences [q-bio], Europe, Chronic Disease, Antiemetics, CANNABINOID HYPEREMESIS SYNDROME, Gastrointestinal Motility, Life Sciences & Biomedicine, Algorithms
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
